Evaluating the CD38+ TIM signature and a previously published TIM signature across LUAD and LUSC TCGA datasets, we observed a dynamic range in each NSCLC subtype with generally equal abundance of TIM subsets (Supplemental Figure 21A) (23). Here, CD38 is linked to non-small cell lung carcinoma.